Earnings History Data for Nautilus Biotechnology, Inc. (NAUT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Nautilus Biotechnology, Inc.
Nautilus Biotechnology Inc. is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus Biotechnology Inc., formerly known as Arya Sciences Acquisition Corp III, is based in SEATTLE.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29-10-2024 | PM | NAUT | Nautilus Biotechnology, Inc. | 252.56 | -0.13 | -0.17 | -0.13 | Nautilus Biotechnology GAAP EPS of -$0.13 beats by $0.04 [10/29/2024 8:06 AM] |
2.76 | -0.05 (-1.78%) |
2.75 | -0.06 (-2.14%) |
2.19 - 3.45 | 90,301 | 80,000 | 1,163 | ||
| 30-07-2024 | PM | NAUT | Nautilus Biotechnology, Inc. | 270.40 | -0.14 | -0.16 | -0.13 | Nautilus Biotechnology GAAP EPS of -$0.14 beats by $0.02 [7/30/2024 8:19 AM] |
2.69 | -0.05 (-1.82%) |
0.0 | 0.0 (0.00%) |
2.19 - 4.00 | 51,415 | 70,000 | 0 | ||
| 30-04-2024 | PM | NAUT | Nautilus Biotechnology, Inc. | 295.23 | -0.15 | -0.16 | -0.12 | Nautilus Biotechnology GAAP EPS of -$0.15 beats by $0.01 [4/30/2024 8:04 AM] |
2.58 | 0.01 (0.39%) |
0.0 | 0.0 (0.00%) |
2.16 - 4.65 | 141,732 | 60,000 | 0 | ||
| 28-02-2024 | PM | NAUT | Nautilus Biotechnology | 351.00 | -0.14 | -0.16 | 0.00 | Nautilus Biotechnology GAAP EPS of -$0.14 beats by $0.01 [2/28/2024 8:04 AM] |
2.82 | -0.12 (-4.08%) |
2.96 | 0.02 (0.68%) |
1.97 - 4.65 | 49,507 | 70,000 | 321 | ||
| 31-10-2023 | PM | NAUT | Nautilus Biotechnology, Inc. | 90.59 | -0.13 | -0.18 | -0.11 | Nautilus Biotechnology GAAP EPS of -$0.13 misses by $0.01 [10/31/2023 9:05 AM] |
2.54 | 0.20 (8.55%) |
2.04 | -0.30 (-12.82%) |
1.50 - 4.65 | 49,868 | 120,000 | 174 | ||
| 02-08-2023 | PM | NAUT | Nautilus Biotechnology, Inc. | 410.81 | -0.13 | -0.17 | -0.12 | Nautilus Biotechnology GAAP EPS of -$0.13 beats by $0.01 [8/2/2023 7:49 AM] |
3.05 | -0.10 (-3.17%) |
2.90 | -0.25 (-7.94%) |
1.50 - 4.65 | 94,660 | 70,000 | 705 | ||
| 02-05-2023 | PM | 6:05 AM ET (May 2) |
NAUT | Nautilus Biotechnology, Inc. | 317.16 | -0.12 | -0.16 | -0.13 | Nautilus Biotechnology GAAP EPS of -$0.12 beats by $0.03 [5/2/2023 6:38 AM] |
2.27 | -0.27 (-10.63%) |
0.0 | 0.0 (0.00%) |
1.50 - 5.07 | 114,787 | 60,000 | 0 | |
| 23-02-2023 | PM | 6:05 AM ET (Feb 23) |
NAUT | Nautilus Biotechnology, Inc. | 278.13 | -0.11 | -0.14 | -0.13 | Nautilus Biotechnology GAAP EPS of -$0.11 beats by $0.03 [2/23/2023 6:07 AM] |
1.85 | -0.15 (-7.50%) |
0.0 | 0.0 (0.00%) |
1.50 - 5.07 | 78,325 | 80,000 | 0 | |
| 01-11-2022 | PM | 6:50 AM ET (Nov 1) |
NAUT | Nautilus Biotechnology, Inc. | 297.95 | -0.11 | -0.14 | -0.12 | Nautilus Biotechnology GAAP EPS of -$0.11 beats by $0.03 [11/1/2022 6:18 AM] |
2.40 | -0.07 (-2.83%) |
2.54 | 0.07 (2.83%) |
1.86 - 6.33 | 138,197 | 140,000 | 1,531 | |
| 02-08-2022 | PM | 6:00 AM ET (Aug 2) |
NAUT | Nautilus Biotechnology, Inc. | 328.58 | -0.12 | -0.17 | -0.19 | Nautilus Biotechnology GAAP EPS of -$0.12 beats by $0.05 [8/2/2022 6:53 AM] |
2.78 | -0.08 (-2.80%) |
2.91 | 0.05 (1.75%) |
2.53 - 12.38 | 467,002 | 140,000 | 340 | |
|
||||||||||||||||||
| 03-05-2022 | PM | 6:00 AM ET (May 3) |
NAUT | Nautilus Biotechnology | 560.00 | -0.13 | -0.15 | 0.00 | Nautilus Biotechnology Non-GAAP EPS of -$0.13 beats by $0.03 [5/3/2022 6:12 AM] |
4.78 | -0.06 (-1.34%) |
4.65 | -0.19 (-3.93%) |
3.36 - 12.38 | 406,838 | 240,000 | 820 | |
| 24-02-2022 | PM | 6:00 AM ET (Feb 24) |
NAUT | Nautilus Biotechnology, Inc. | 454.45 | -0.13 | -0.15 | 0.00 | Nautilus Biotechnology GAAP EPS of -$0.13 in-line [2/24/2022 6:04 AM] |
4.15 | -0.04 (0.00%) |
0.0 | 0.0 (0.00%) |
3.94 - 25.89 | 312,702 | 452,050 | 0 | |
| 02-11-2021 | PM | 6:00 AM ET (Nov 2) |
NAUT | Nautilus Biotechnology, Inc. | 676.35 | -0.12 | -0.11 | 0.00 | Nautilus Biotechnology reports Q3 results [11/2/2021 6:03 AM] |
5.83 | 0.39 (7.17%) |
5.83 | 0.0 (0.00%) |
5.08 - 25.89 | 887,166 | 430,000 | 463 | |
|
||||||||||||||||||
| 10-08-2021 | PM | 7:00 AM ET (Aug 10) |
NAUT | Nautilus Biotechnology, Inc. | 927.86 | -0.19 | -0.09 | 0.00 | Nautilus Biotechnology reports Q2 results [8/10/2021 6:29 AM] |
7.60 | -0.38 (-4.76%) |
7.93 | -0.05 (-0.63%) |
7.28 - 25.89 | 594,763 | 3,290,000 | 17,496 | |